Effects of Pelvic Belt and Kinesio Tape on Pain and Functional Mobility in Pregnancy-Related Pelvic Girdle Pain

Pelvic Girdle Pain Clinical Trial

Official title:

Gebeliğe Bağlı Pelvik Kuşak Ağrısında Pelvik Kemer ve Kinezyo Bant Uygulamalarının Ağrı ve Fonksiyonel Mobilite Üzerine Etkileri

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04266184
• Other study ID #: 47921137-050.01.04-E.144981
• Status: Recruiting
• Phase: N/A
• Start date: March 13, 2020
• Est. completion date: February 2022

Study information

• Verified date: March 2021
• Source: Mugla Sitki Koçman University
• Contact: Ilkim Çitak Karakaya
• Phone: 05323611451
• Email: ilkim74[@]yahoo.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study investigates the effects of pelvic belt (PB) and kinesio taping (KT) applications on pain and functional mobility in pregnancy-related pelvic girdle pain (PGP), in comparison with the control group that received only pain neuroscience education and ergonomic training.

Description:

Although there is strong evidence in the literature that pelvic support belts reduce pain in pregnancy-related pelvic girdle pain, no study investigating its effect on functional mobility with performance-based measurement methods or investigating its effectiveness on kinesiophobia has been found. Studies investigating the efficacy of KT in pregnant women with PGP are few and many are methodologically weak studies, most of which do not contain randomization and control groups. Also, no study has been found in the literature, which compares the effectiveness of PB and KT in pregnant women with PGP. Therefore, the primary aim of this study is to examine the effects of PB and KT on pain and functional mobility in pregnant women with PGP in comparison with the control group, which is only given pain neuroscience education and ergonomic training. The secondary aims are to investigate the effects of these applications on kinesiophobia, activity limitation and sleep quality; and to compare the groups in regard to patient compliance and treatment satisfaction levels of the groups.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 47
• Est. completion date: February 2022
• Est. primary completion date: December 2021
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• being able to read and write in Turkish

• being in 2nd or 3rd trimester of pregnancy

• having PGP for more than one week

• signing the informed consent form for the study

Exclusion Criteria:

• visual, auditory or cognitive problems which may prevent participation to the study

• health problems other than pregnancy-related PGP (orthopedic, neurologic, cardiorespiratory, etc.) or trauma history, which may affect standing from sitting, walking or stair climbing activities

• any gynecological or urological problems which may mimic pregnancy related PGP

• any diagnosed pregnancy complications other than PGP (preeclampsy, hypertension, diabetes,placental/fetal anomaly, preterm labor, etc.)

• high risk pregnancy (multiple gestation, etc.)

• history of spinal injury, ankylosing spondilitis, rheumatoid arthritis, intervertebral disc pathology)

• A positive straight leg raise test result, as well as sensory or motor deficits indicating intervertebral disc pathology

• history of prepregnancy low back or pelvic girdle pain

• using any analgesic or myorelaxant medication

• contraindications to KT or PB (impaired skin integrity or lesion in the lumbopelvic and abdominal regions, history of allergic reaction, etc.)

• previous KT (abdominal or lumbosacral) or PB experience

Related Conditions & MeSH terms

• Pelvic Girdle Pain

Intervention

Other:
• Kinesio tape (KT)
For abdominal taping, four I-shaped tapes will be used. Two of them will start from the superior symphisis pubis, follow the rectus abdominis muscle, and finish at the xiphoid process. Other two I-shaped tapes will start from the mid-symphisis pubis, follow the external oblique abdominals, and finish at the spina iliaca anterior superiors. Symphisis pubis taping will be applied with two I-shaped tapes, by forming a "X" shape. For lumbopelvic taping, three I-shaped KTs will be used. Two tapes will be applied bilaterally and longitudinally on the lumbar erector spinal muscles. The third tape will start from one sacroiliac joint and end at the other, vertically to the previous two tapes, forming a H-shape. All tapings will be applied with 15-25% tension (tape-off tension). KTs will stay three days. They will be removed from the site, and the skin will be checked and cleaned. Then, they will be reapplied for the next three days.
• Pelvic belt (PB)
The women in this group will use the belts, after adjusting them at a comfortable tension, after getting up the bed in the mornings, during daily activities and walking. Evaluation will be made three days after the first application and they will be asked to continue using it for the second three-day period.
• Educational program
This program will include pain neuroscience education and ergonomic education, and will approximately last one hour.

Locations

Country	Name	City	State
Turkey	Bezmialem Vakif University	Istanbul

Sponsors (2)

Lead Sponsor	Collaborator
Mugla Sitki Koçman University	Bezmialem Vakif University

Country where clinical trial is conducted

Turkey, 

References & Publications (4)

Bertuit J, Van Lint CE, Rooze M, Feipel V. Pregnancy and pelvic girdle pain: Analysis of pelvic belt on pain. J Clin Nurs. 2018 Jan;27(1-2):e129-e137. doi: 10.1111/jocn.13888. Epub 2017 Nov 3. — View Citation

Bodes Pardo G, Lluch Girbés E, Roussel NA, Gallego Izquierdo T, Jiménez Penick V, Pecos Martín D. Pain Neurophysiology Education and Therapeutic Exercise for Patients With Chronic Low Back Pain: A Single-Blind Randomized Controlled Trial. Arch Phys Med Rehabil. 2018 Feb;99(2):338-347. doi: 10.1016/j.apmr.2017.10.016. Epub 2017 Nov 11. — View Citation

Draper C, Azad A, Littlewood D, Morgan C, Barker L, Weis CA. Taping protocol for two presentations of pregnancy-related back pain: a case series. J Can Chiropr Assoc. 2019 Aug;63(2):111-118. — View Citation

Louw A, Diener I, Butler DS, Puentedura EJ. The effect of neuroscience education on pain, disability, anxiety, and stress in chronic musculoskeletal pain. Arch Phys Med Rehabil. 2011 Dec;92(12):2041-56. doi: 10.1016/j.apmr.2011.07.198. Review. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	change in general pain intensity during activity	The women will be asked to mark their pain intensity during activities in general. 0 (no pain)-10 cm (unbearable pain) visual analogue scale will be used.	baseline, approximately one-hour after the first intervention, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
Primary	change in pain intensity during five times sit to stand test	The women will be asked to mark their pain intensity during five times sit to stand test. 0 (no pain)-10 cm (unbearable pain) visual analogue scale will be used.	baseline, approximately one-hour after the first intervention, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
Primary	change in pain intensity during five-stairs climbing test	The women will be asked to mark their pain intensity during five-stairs climbing test. 0 (no pain)-10 cm (unbearable pain) visual analogue scale will be used.	baseline, approximately one-hour after the first intervention, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
Primary	change in pain intensity during timed up and go test	The women will be asked to mark their pain intensity during timed up and go test. 0 (no pain)-10 cm (unbearable pain) visual analogue scale will be used.	baseline, approximately one-hour after the first intervention, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
Primary	change in impairment during active straight leg raise test	The women will be asked to score their impairment during active straight leg raise test. 0 (not difficult at all)-5 (unable to do) scoring system will be used. Scores for right and left legs will be summed and recorded.	baseline, approximately one-hour after the first intervention, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
Secondary	change in kinesiophobia	Turkish version of Tampa Kinesiophobia Scale will be used. The score ranges between 17 and 68, and higher score indicates higher kinesiophobia.	baseline, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
Secondary	change in activity limitation	Turkish version of Pelvic Girdle Questionnaire will be used. Total score varies between 0 and 75, and higher score indicates higher activity limitation.	baseline, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
Secondary	change in sleep quality	Quality of sleep will be assessed on a 0 (very bad)-10 (very good) cm VAS.	baseline, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
Secondary	patient compliance	For PB and KT groups, comfort and easiness of using PB and KT will be assessed by 0 (not at all)-10 (extremely comfortable/easy) cm VASs. All groups will be questioned about the comprehensibility of the educational program on 0 (not at all)-10 (completely comprehensible) cm VASs. Also, degree of following the suggestions given in the educational program will be evaluated by 0 (not at all)-10 (completely) cm VASs.	baseline, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention
Secondary	treatment satisfaction	Treatment satisfaction will be assessed by 0 (not at all)-10 (extremely satisfactory) cm VASs.	baseline, three days after the first intervention, one week after the first intervention, and one week after cessation of intervention